3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Melanoma
2
Sarcoma, Kaposi
1
Interventions
talimogene laherparepvec
1
pembrolizumab
1
daromun
1
Vincristine
1
Therapeutics
1
Psychiatric Rehabilitation
1
Liposomes
1
Doxorubicin
1
Diagnostic Tests, Routine
1
Bleomycin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Sarcoma, Kaposi
×
talimogene laherparepvec
×
Clear all
NCT04065152
2022-06-10
KAPVEC
Assistance Publique - Hôpitaux de Paris
Phase 2
Unknown
20 enrolled